ASHPOfficial

In this podcast episode, members of the New Practitioners Forum Career Development Advisory Group interview two pharmacy leaders on their perspectives of impostor syndrome and how it's impacted their personal and professional lives. The speakers help define impostor syndrome and provide words of wisdom to new practitioners and beyond when facing impostor syndrome. For additional resources on combatting impostor syndrome, check out the new resource outline developed the New Practitioners Forum. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Within a health system, student pharmacists on rotation often are responsible for making numerous clinical interventions. However, oftentimes students are not engaged in the clinical intervention documentation, and do not have the opportunity to practice and develop their documentation skills prior to going into independent practice as a pharmacist. In this episode of Educator Essentials, we talk about implementing a standardized method for tracking student pharmacist interventions in the inpatient setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Specialty pharmacy practice doesn’t always mean exotic or expensive drugs; it's often the work done to get those products paid for and ensure patient access and timely start of therapy. Members of this group outline what work really makes their team special and how they contribute to patient care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode provides an overview of the available weight loss medications and walks through how to approach a patient case. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Medication excipients (often-referred to as inactive ingredients) provide several functions, such as serving as binders, disintegrants, solubilizers, preservatives, and/or assisting with pH adjustment. However, medication excipients may cause adverse events or allergic reactions in some patients. Several regulatory and technological gaps exist that hinder practitioners from preventing adverse events and allergic reactions related to these excipients. This podcast is intended to bring awareness to current regulatory and technological gaps associated with managing medication excipient allergies and intolerances, highlight common operational challenges involved with identifying and preventing medication excipient allergic reactions, and provide current “best practices” to address these issues. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode explores the intersection of clinical pain management and the relatively newer concept of “opioid stewardship” within the context of pharmacy practice. Listeners will receive an overview of institutional pain management and opioid stewardship programs, as well as learn how these conceptual frameworks for healthcare practice compare and contrast. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode will provide an overview of pharmacy informatics and how residency programs in this field can help learners prepare to become an informaticist. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join members from the ASHP Section of Inpatient Care Practitioners Compounding Section Advisory Group for a discussion on “Compounding Conundrums.” Each speaker will reflect on a recent challenge they have faced, briefly describe the challenge, and discuss how they addressed it. We aim to share innovative approaches to problems faced by our pharmacy peers, specifically those involved with or overseeing compounded sterile preparations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode explores leadership strategies and skills needed to stay relevant in healthcare. The speakers describe how they keep up with the changes in managing healthcare technology, as well as how ASHP has contributed to their ability to keep pace with these changes. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and their need for accreditation to support their clinical services and operations. In addition, listeners will learn strategies to address ongoing maintenance and compliance of the standards set by the accrediting body before re-accreditation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The ASHP Well-Being Ambassador Program (WBA) is a curriculum-based, virtual learning community that will empower local action, particularly in tribal, rural, and underserved areas, to mitigate occupational burnout in healthcare organizations. The work is being funded through a three-year grant from the Health Resources and Services Administration (HRSA) Health and Public safety Workforce Resiliency Training Program. Today’s podcast episode will discuss this opportunity. Learn more about becoming an ASHP well-being ambassador: https://wellbeing.ashp.org/wellbeing/well-being-ambassador-program The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores the introduction of the Equitable Community Access to Pharmacist Services Act (H.R. 7213) by Congress. Tom Kraus discusses what the bill does, how it will impact pharmacy, what is the path forward, and what ASHP members can do to advance the legislation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, we will explore development of interprofessional teams that embrace pharmacy learners. The goal is to help arm academic pharmacists with candid insights on how to approach providers and practices with creating and developing integrated pharmacy services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Atrial fibrillation is the most common abnormal heart rhythm and has tripled in prevalence of the last 50 years. Approximately 20% of patients with atrial fibrillation may not even know that they have the arrhythmia. This podcast episode will provide insight into the importance of undiagnosed atrial fibrillation and will give practical tips to the pharmacist interested in developing a screening program for identifying undiagnosed atrial fibrillation. To learn more, visit www.ashpadvantage.com/nvaf The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, Dr. William Anthony Hawkins, Dr. Charles (CJ) Wilson, and Dr. Michael Long discuss their article, “From Theory to Bedside: Implementation of Fluid Stewardship in a Medical ICU Pharmacy Practice,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Jessica Spangler, PharmD is a PGY-1 pharmacy resident who uses her passion for personal finance to educate others on social media. With over 300,000 followers, Jessica has turned this passion into an entrepreneurial venture on various social media platforms. Jessica will share how she got interested in both pharmacy and personal finance, and how she is using her knowledge and skills in both to reach her audience. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

One core outcome of a residency is learning how to precept. In this episode of Educator Essentials, we talk about how incorporating the four preceptor roles of Instructing, Modeling, Coaching, and Facilitating throughout the resident’s year can increase their precepting confidence and success. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this podcast episode, the faculty will delve deeper into the integration of central fill into the business of their respective health systems, including key objectives and whether those were met. Considerations for the buildout, taking into consideration the proximity to the health-system’s pharmacies will also be discussed. The podcast will conclude with discussion of staff reaction to central fill during all phases of the process (pre-implementation, during implementation, and post-implementation). The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, our content matter expert reviews the literature on measurement, treatment and prophylaxis recommendations related to anticoagulation in critically ill COVID-19 patients and reviews management considerations for special ICU populations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In 2018, state health departments received funding to support diabetes and cardiovascular disease prevention and management efforts under a 5-year cooperative agreement with the Centers for Disease Control and Prevention (CDC). The Alaska Department of Health and Social Services Section of Chronic Disease Prevention and Health Promotion partnered with the Alaska Pharmacists Association (AKPhA) in funding the Sustainable Education and Training Model under Pharmacist Provider Reimbursement (SETMuPP) program. This podcast episode summarizes the initial accomplishments and provides a framework for other groups invested in provision and sustainability of pharmacist-provided health services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the 2021 Midyear Clinical Meeting, our content matter expert evaluates the literature and explores the role that immunomodulators and antivirals may (or may not play) for the management of COVID-19 infection in the critically ill. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This presentation focuses on outpatient infectious diseases topics, specifically focusing on sexually transmitted infections (STI) treatment strategies. Content experts discuss recent guideline updates, changes in recommended therapies, dosing strategies, and other clinical considerations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, listeners will learn about the journey of few health-system specialty pharmacies and the need for the accreditation to support their clinical services and operations. In addition, listeners will also learn on how to continue the ongoing maintenance and compliance of the standards set by the accrediting body before the re-accreditation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will overview real world examples of technician retention and recognition programs, and will feature an interview with technician leaders from two institutions to gain insight to their experiences and preferences related to technician retention and recognition programs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP is committed to advancing the field of pharmacogenomics and educating members on the impact of pharmacogenomics testing, dosing, and monitoring of medications on improved health outcomes. This podcast explores the new Pharmacogenomics Accelerator program from ASHP in partnership with the University of Minnesota College of Pharmacy including program goals, value to participants, enrollment process, and more. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, content matter experts evaluate primary literature and guideline recommendations for the managing sedation and analgesia in critically ill patients hospitalized with COVID-19. We also review the role post ICU clinics play in managing these patients after discharge. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as we hear from Jessica Perlo, Senior Director at the Institute for Healthcare Improvement. As an Improvement Advisor, Jessica has led many initiatives in IHI to address burnout and restore individual wellness including a focus on restoring joy to the health care workforce, and the Healthcare Workforce Rescue Package from the All In Well-Being Campaign. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/ The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Intensive care unit (ICU) delirium is a common and severe manifestation of critical illness. It can occur in up to 80% of mechanically ventilated ICU patients and leads to longer lengths of stay and increases the risk of mortality. The etiology of ICU delirium is not well-elucidated, making pharmacological treatments difficult to target. This podcast will discuss the risk factors, definitions, and treatment of ICU delirium. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, Doug Scheckelhoff, Dr. Chuck Daniels, and Lynnae Mahaney discuss the ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice, with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meetings, researchers with the support of the ASHP Foundation share the preliminary results of their ongoing study that looks at satisfaction levels of pharmacy technicians working in ambulatory care. Their research is also seeking to obtain a deeper understanding of variation in the roles of pharmacy technicians in the ambulatory care setting and explore factors influencing job satisfaction and dissatisfaction. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode of educator essentials explores the use of escape rooms for evaluating candidates during pharmacy residency interviews. Our panelists explore this creative approach to interviewing as a way to evaluate candidates’ communication, collaboration, and clinical skills, while having fun. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As a special edition Patient Safety Awareness Week podcast, speakers discuss their work on the National Quality Forum’s Action Team on Person-Centered Medication Safety. The co-chairs of this Action Team highlight the priority challenges and recommendations for stakeholders to take away from this work. Additionally, they discuss creating meaningful partnerships with patients, families, and caregivers and outlining practical steps that hospitals and health systems can take to implement better person-centered medication safety. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode shares the experiences of pharmacists that went through the Phase II Match. Listeners will learn about their pharmacy school career goals, feelings on Phase I Match Day, and how they prepared and refocused to enter into the Phase II Match. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on key issues for safe neuromuscular blockade and reversal. Discussion includes Intraoperative neuromuscular monitoring, dosing of reversal agents, and reversal strategies. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meeting, this featurette discusses the models of infusion services that health systems can provide, the implication of white bagging on patient care, and discusses the best practices in revenue cycle management related to high-cost infusion services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we discuss one of the ways the pharmacy department at Yale New Haven Hospital has ensured technician engagement across their department. Tune in to learn about how technicians are incorporated into strategic planning for the department, and to hear a first-person technician account about the successes with this strategy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This presentation focuses on outpatient infectious diseases topics, specifically focusing on HIV prevention. Content experts discuss recent guideline updates, new medications, medication access, and implications in the outpatient setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A conversation with the 2021-2022 Chair of the ASHP Section of Ambulatory Care Practitioners (SACP). Listeners will learn about Danny’s pharmacy practice experience, ASHP involvement, and how he’s adapted his SACP leadership term to the continued navigation of the COVID-19 pandemic. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, we chat with Dr. Garrett Schramm, Director of Pharmacy Education and Academic Affairs at Mayo Clinic – Rochester, about the value of community-based pharmacy residencies in training future leaders. Dr. Schramm reviews his organization's pursuit of expanding available pharmacy residencies in community-based practice at Mayo, and the importance of quality training for future practice leaders. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During the COVID-19 pandemic, rapid changes were needed to support fluctuating patient care needs, such as conversion of patient care units to COVID-19 care areas, transformation of level of care (e.g., general floors becoming intensive care units (ICUs)), and modifications to patient populations on units (e.g., pediatric units supporting adult patients). Listeners will learn how automated dispensing cabinets can inventory can be assessed efficiently when patient populations are rapidly changing and explain the importance of including a broad group of health-system stakeholders for planning operations during emergency situations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.